BIOCARDIA ANNOUNCES FDA ACCEPTANCE OF DE NOVO PRE-SUBMISSION PACKAGE FOR HELIX™ CATHETER MARKETING CLEARANCE FDA SUBSTANTIVE REVIEW AND MEETING EXPECTED THIS QUARTER

Reuters · 2d ago

Please log in to view news